Industry › Clinical Trials
Press Releases
NEC Announces Interim Results from Phase 1 Clinical Trial of NECVAX-NEO1, an AI-Driven Personalized Oral Cancer Vaccine, at ESMO Immuno-Oncology Congress 2024
NEC Corporation
Dec 12, 2024 15:27 HKT/SGT
VisiRose Introduces Revolutionary Therapy for Severe Eye Infections
VisiRose, Inc.
Dec 10, 2024 20:30 HKT/SGT
HighTide Therapeutics to Present Analyses of Phase 2 MASH Study at AASLD's The Liver Meeting 2024
HighTide Therapeutics Inc.
Oct 25, 2024 08:57 HKT/SGT
GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis
GEN Pharmaceuticals
Sep 25, 2024 21:00 HKT/SGT
EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies, Highlighting Benefits of Berberine Ursodeoxycholate (HTD1801)
HighTide Therapeutics Inc.
Sep 11, 2024 12:00 HKT/SGT
EASD 2024 | 君圣泰医药口头报告熊去氧胆小檗碱（HTD1801）在T2DM中的两项事后分析
HighTide Therapeutics Inc.
Sep 11, 2024 11:51 HKT/SGT
EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies, Highlighting Benefits of Berberine Ursodeoxycholate (HTD1801)
HighTide Therapeutics Inc.
Sep 11, 2024 11:34 HKT/SGT
EASD 2024 | 君聖泰醫藥口頭報告熊去氧膽小檗碱（HTD1801）在T2DM中的兩項事後分析
HighTide Therapeutics Inc.
Sep 11, 2024 11:16 HKT/SGT